B

Brooklyn Clinical Research | New York, NY

Research site

(Unclaimed)

Location

150 Lenox Road, Brooklyn, New York, United States of America

Site insights

Top conditions

Top treatments

SUZ

Suzetrigine

Lenacapavir

VPV

GS-3242

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS...

Enrolling

HIV-1-infection

Drug: Lenacapavir Injection

Drug: GS-3242 Injection

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza (ANCHOR)

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo

A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis (Nova 301)

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Biological: mRNA-1403

Biological: Placebo

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic per...

Enrolling

Diabetic Peripheral Neuropathic Pain

Drug: Placebo (matched to SUZ)

Drug: Suzetrigine

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD (Cardinal COPD)

Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduc...

Enrolling

Rhinovirus Infection

Other: Placebo

Drug: VPV 500 mg